Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.86 -0.13 (-2.61%)
At close: Aug 20, 2026 · 4:00 PM EDT

Verrica Pharmaceuticals (VRCA) Work In Process (2023 - 2025)

Verrica Pharmaceuticals (VRCA) posted quarterly Work In Process of $523000.0 for Q2 2025, down 23.43% year-over-year from $683000.0 in Q2 2024, and up 192.18% quarter-over-quarter from $179000.0 in Q1 2025.

Verrica Pharmaceuticals (VRCA) Work In Process (2023 - 2025) Analysis & Trends

Verrica Pharmaceuticals' Work In Process history runs 3 years deep, the most recent figure standing at $523000.0 for Q2 2025.

  • In Q2 2025, Work In Process fell 23.43% year-over-year to $523000.0; the TTM figure through Jun 2025 stood at $523000.0 (down 23.43% YoY), while the FY2024 annual figure was $664000.0, up 36.34% from the prior year.
  • Work In Process for Q2 2025 stood at $523000.0, up from $179000.0 in the prior quarter.
  • The five-year high for Work In Process was $750000.0 in Q3 2024, with the low at $179000.0 in Q1 2025.
  • The 3-year median for Work In Process is $664000.0 (2024), against an average of $564857.1.
  • The sharpest annual moves came in 2024 and 2025: Work In Process surged 36.34% in 2024, then tumbled 73.2% in 2025.
  • Verrica Pharmaceuticals' Work In Process stood at $487000.0 in 2023, then soared by 36.34% to $664000.0 in 2024, then slipped by 21.23% to $523000.0 in 2025.
  • Business Quant data shows VRCA's Work In Process at $523000.0 in Q2 2025, $179000.0 in Q1 2025, and $664000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Verrica Pharmaceuticals 104.71 Mn 93.51 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 523,000.00
Mar 31, 2025 179,000.00
Dec 31, 2024 664,000.00
Sep 30, 2024 750,000.00
Jun 30, 2024 683,000.00
Mar 31, 2024 668,000.00
Dec 31, 2023 487,000.00